Efficient Tet-Dependent Expression of Human Factor IX in Vivo by a New Self-Regulating Lentiviral Vector
Open Access
- 31 May 2005
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 11 (5), 763-775
- https://doi.org/10.1016/j.ymthe.2004.11.017
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Gene therapy progress and prospects: transcription regulatory systemsGene Therapy, 2004
- Global analysis of cellular transcription following infection with an hiv-based vectorMolecular Therapy, 2003
- Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivoGene Therapy, 2003
- Dose-Dependent Neuroprotective Effect of Ciliary Neurotrophic Factor Delivered via Tetracycline-Regulated Lentiviral Vectors in the Quinolinic Acid Rat Model of Huntington's DiseaseHuman Gene Therapy, 2002
- Latest developments and in vivo use of the Tet system: ex vivo and in vivo delivery of tetracycline-regulated genesCurrent Opinion in Biotechnology, 2002
- Robust and Efficient Regulation of Transgene Expression in Vivo by Improved Tetracycline-Dependent Lentiviral VectorsMolecular Therapy, 2002
- Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeuticsNature Medicine, 2001
- Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapyThe Journal of Gene Medicine, 2000
- Lentiviral Vectors: Regulated Gene ExpressionMolecular Therapy, 2000
- Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advancesMethods in Enzymology, 2000